Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?

Investigation into predictors for treatment outcome is essential to improve the clinical efficacy of therapeutic multipotent mesenchymal stromal cells (MSCs). We therefore studied the possible harmful impact of immunogenic ABO blood groups antigens – genetically governed antigenic determinants – at...

詳細記述

保存先:
書誌詳細
主要な著者: Moll, Guido, Hult, Annika, von Bahr, Lena, Alm, Jessica J., Heldring, Nina, Hamad, Osama A., Stenbeck-Funke, Lillemor, Larsson, Stella, Teramura, Yuji, Roelofs, Helene, Nilsson, Bo, Fibbe, Willem E., Olsson, Martin L., Le Blanc, Katarina
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2014
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3890285/
https://ncbi.nlm.nih.gov/pubmed/24454787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0085040
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料